Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-03-22
    E.g., 2018-03-22


64 items
12:00 AM, Aug 16, 2012  |  BC Innovations | Finance

CIRM: get a little closer

In its latest batch of grants the California Institute for Regenerative Medicine divided a smaller pool of funding among fewer research teams than it did in 2009, reflecting the institute's interest in funding projects that...
12:00 AM, Mar 29, 2012  |  BC Innovations | Finance

IMI's leadoff hitter

Europe's Innovative Medicines Initiative has recruited 7 pharmas to each contribute up to 50,000 compounds from their proprietary libraries and is pooling the molecules into a public-private partnership called the European Lead Factory. The pharmas...
12:00 AM, Aug 04, 2011  |  BC Innovations | Finance

Gap-filling alliance

BioPontis Alliance LLCis taking a fresh approach to addressing the translational gap-instead of taking discoveries from universities and forming companies, BioPontis starts with its knowledge of industry's portfolio needs and works backward. The company hopes...
12:00 AM, May 19, 2011  |  BC Innovations | Finance

Making the case for precompetitive clinical development

The Structural Genomics Consortium and Sage Bionetworks are spearheading an effort to build a precompetitive, pharma-backed public-private partnership to optimize the clinical validation of new therapeutic targets. By removing IP and data-access restrictions, the group...
12:00 AM, May 12, 2011  |  BC Innovations | Finance

Agilent synthesizes partnerships

In the last seven months, Agilent Technologies Inc. has entered into two major partnerships with newly formed academic institutes focused on synthetic biology. The company thinks synthetic biology is strategically important because it encompasses all...
12:00 AM, Apr 28, 2011  |  BC Innovations | Finance

Translational biology with a clinical mindset

Attracted by INSERM's large network of labs and hospitals, MedImmune LLC has formed a strategic collaboration with the institute to explore translational biology and novel disease mechanisms with an eye to streamlining the flow of...
12:00 AM, Mar 10, 2011  |  BC Innovations | Finance

KICk-starting European enterprise

After cutting its teeth with investments in energy and communications in 2010, the European Institute of Innovation and Technologyis making long-term plans for a move into the biopharmaceutical space. To do so, the institute has...
12:00 AM, Oct 28, 2010  |  BC Innovations | Finance

Singapore's new tune

After more than two decadesof investing inlife science infrastructure, Singapore is now shifting its focus totranslational research with near-term commercial applications and clear economic outcomes. To do so, the country isallocating S$3.7 billion ($2.8 billion)...
12:00 AM, Apr 29, 2010  |  BC Innovations | Finance

Beta testing in diabetes

Conventional wisdom holds that the only way to generate new islet cells in people with type 1 diabetes is through cell therapy. A trio of recent deals, however, suggests that some companies and not-for-profit organizations...
12:00 AM, Mar 11, 2010  |  BC Innovations | Finance

Orienting cancer

Eli Lilly and Co., Merck & Co. Inc. and Pfizer Inc. have joined in a precompetitive deal to study the pharmacogenomics of Asian cancer patients. By jointly gathering molecular epidemiology information on a large scale,...